The international journal of neuropsychopharmacology

Ketamine's effects on brain activity and therapy links vary in treatment-resistant depression, PTSD, and OCD

Updated

Abstract

All neurotic disorders may respond quickly to low dose ketamine (0.5-1.0 mg/kg I.M.), even when resistant to conventional treatment.

  • Neurotic disorders include major depressive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder, and specific phobia.
  • Each disorder has a unique response to various pharmaceutical treatments.
  • Low doses of ketamine have been shown to induce rapid responses in these disorders.
  • This response may occur despite resistance to traditional treatment options.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Prof Glue disclosed a contract with Douglas Pharmaceuticals to develop novel ketamine formulations. All other authors declared absence of biomedical financial interests or potential conflicts of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free